•  Whats App +1 (443) 595-6199
  •  contact@mavenscience.com


Open Access Policy

  • The published final version of the articles is accessible to anyone and available for download and reuse in a seam-less and unrestricted manner provide, the original contributors and the source is acknowledged and cited appropriately.
  • Under open access policy, the articles are published with a Creative Commons Attribution Licensing term. The degree to which the articles can be shared and the condition of reuse is determined by the type of CC BY license terms.
  • Since the open access articles are free to distribute, the processing and production cost of the open access articles is chargeable. Contributing authors or their funding body/agency need to pay for the standard Article Processing Charge (APC) in order to publish under open access licensing terms. The authors retain the copyright of their contribution.
  • All the manuscripts accepted for publication after the peer-review are published under gold open access model of publication either with CC BY 4.0 or CC BY-NC 4.0 licensing terms. A standard one time article processing charge is applicable payable by author, institutions open access fund, or funding or sponsoring agency.


Licensing & Copyright Policy

  • The authors, their organizations open access fund regulators, funding agencies are given an option to make a choice on the type of International creative commons attributions license for gold open access articles accepted for publication.
  • The authors grant the publisher, an unlimited license to publish the open access article under the preferred creative commons attribution license as well as to regulate and monetize third party usage.
  • By default, all accepted articles are published under gold open access model of publication with creative commons attribution non-commercial license 4.0, CC BY-NC [4.0] wherein, the articles can be read, shared and distributed for non-commercial purposes, provide the original author and the source of publication are appropriately cited and acknowledged. The work represented in the article cannot be used for commercial purposes. However, intent for commercial usage necessitates procurement of written permission and payment of appropriate licensing fee.
  • Authors shall permit the publisher to apply a DOI to their articles.


Publication Ethics & Malpractice Statement

  • All the submitted manuscripts are subjected to in-house quality assessment for publication worthiness and editorial review for evaluation of potential scientific merit and publication standards.
  • The publication policy is based on Committee on Publication Ethics (COPE) guidelines for editorial processing, article production, online publication, corrections, retractions, withdrawals and expression of concerns.
  • International Committee of Medical Journals Editors (ICMJE) recommendationsare followed for the editing, reporting and publication of scientific work in medical journals.
  • Major experimental or methodological errors, fabrication of data, unexplained plagiarism, and unethical research lead to retraction of the publication.
  • Institutional ethical committee approvals, government approval and informed consents as applicable to specific fields of research are ensured prior to online publication of the article.
  • If third party information is included in the publication then the source is ensured to be appropriately acknowledged and cited.


Peer-review Policy

  • Editor-in-chief and the editorial board members determined the suitability of the manuscript for peer-review. The managing Editor then forwards the manuscript for analysis and evaluation to subject expert who is either suggested by the author or by the editorial board, such that there is no conflict of interest. Based on the reviewer comments, suggestions and recommendations as well as the revision made, the final editorial decision on the manuscript is made. A closed double blind peer-review is conducted maintaining the anonymity of the peer-reviewers. However, a record of the pre-publication versions, the review comments and the peer reviewer details are maintained for Journal evaluation purpose.


Conflict of Interest

  • A conflict of interest may arise when the author, reviewer, or editor has any common financial, personal, political or ideological interests based on employment, consultancy, honorarium, grants, royalties, patent, ownership or professional association that may potentially influence the final decision-making process. The journal insists on declaration of any potential conflict of interest by the authors before the publication of the article.
  • If no conflict of interest exists for the research, then the authors have to disclose no potential conflicts of interest either financial or otherwise.


Human and Animal Rights Policy

  • Compliance to Helsinki Declaration of the World Medical Association in 1975 as revised in 2008 concerning Human and Animal Rights as well as National or International guidelines is checked.
  • Human experimentation studies should comply with the Declaration of Helsinki, and the research protocol must be approved by the locally appointed ethics committee.
  • Informed consent must be obtained from the subjects (or their legally authorized representative) which must be stated in the manuscript.
  • If the study involves experiments on animals, the author/s should clearly state that the experimental study protocol has been approved by the Institutional Animal Ethics Committee constituted as per the guidelines laid by the committee for the purpose of control and supervision of experiments on Animals.
  • Authors should observe high standards with respect to publication ethics as set out by the Committee on Publication Ethics (COPE) and ICMJE recommendations for reporting information of patients. Patients have a right to privacy that should not be infringed without prior informed consent.
  • Authors are expected to comply with bio-safety and bio-security protocols as recommended by the National and International recommendations and guidelines.
  • Identifying information should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or their legally authorized representative) has given written informed consent for publication. Informed consent for this purpose requires the patient be shown the manuscript to be published.
  • Identifying details should be omitted if they are not essential, but patient data should never be altered or falsified to attain anonymity.
  • A statement addressing informed patient consent must be included as part of the manuscript.


Withdrawal Policy

The corresponding author can withdraw the submitted article within 7 days of manuscript ID allocation or the initial submission date.


Correction and Retraction Policy

  • If any errors are detected that could potential affect the publication record, scientific integrity, author or Journal impact, then necessary corrections are made along with issue of relevant notification. On the other hand if any additions are mandatory for comprehension of the published article, then addendums along with notifications are published.
  • The submitted manuscripts with substantial plagiarized content are not considered for further processing and the authors are duly informed if they would like to resubmit an improved version. Depending on the degree and extent of systematic plagiarism the final version of the article may be retracted along with display of a retraction note.


APC Waiver, Discount & Refund Policy

A standard one-time payment of article processing charge is applicable for each accepted article.  However, waivers and discounts can be considered depending on the scientific merit and impact, source of the manuscripts such as those from under developed and developing countries or for authors lacking substantial funding support. Refund is not applicable after peer-review of the manuscript. However, authors can claim partial refund based on the publishing and editorial processing status and stage.